Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Judge, Sarah M ^a   Wu, Chia Ling ^b   Beharry, Adam W ^a   Roberts, Brandon M ^a   Ferreira, Leonardo F ^a   Kandarian, Susan C ^b   Judge, Andrew R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Cebpb; Extracellular matrix; Fos; Microarray; Muscle Atrophy; Proteasome; Transcription factors; Z disc

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; PROTEASOME; PROTEIN FOS; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; TRANSCRIPTION FACTOR UBR2; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CEBPB GENE; CELL LINE; COLON 26 CELL LINE; COLON CANCER; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DISEASE ASSESSMENT; FOS GENE; GENE ACTIVATION; GENE CONSTRUCT; GENE TARGETING; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOME ANALYSIS; LOCOMOTION; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; STAT3 GENE; TRANSCRIPTION REGULATION; UBR2 GENE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; COLON TUMOR; COMPLICATION; DEPENDOPARVOVIRUS; DISEASE MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; REPRODUCIBILITY; SEQUENCE ALIGNMENT; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; CACHEXIA; COLONIC NEOPLASMS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC VECTORS; GENOME-WIDE ASSOCIATION STUDY; HETEROGRAFTS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PROTEASOME ENDOPEPTIDASE COMPLEX; REPRODUCIBILITY OF RESULTS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 84926686941     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-997     Document Type: Article

References (61)

1. Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev 2009,89(2):381-410. 10.1152/physrev.00016.2008
2. Andreyev HJ, Norman AR, Oates J, Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998,34(4):503-9. 10.1016/S0959-8049(97)10090-9
3. Donohoe CL, Ryan AM, Reynolds JV: Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract 2011, 2011:601434.
4. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME: Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008,12(7):1193-201. 10.1007/s11605-008-0505-z
5. Smith KL, Tisdale MJ: Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 1993,67(4):680-5. 10.1038/bjc.1993.126
6. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, Carathers M, et al.: Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 2005,8(5):421-32. 10.1016/j.ccr.2005.10.004
7. He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J, et al.: NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest 2013,123(11):4821-35. 10.1172/JCI68523
8. Onesti JK, Guttridge DC: Inflammation based regulation of cancer Cachexia. BioMed Res Int 2014, 2014:168407.
9. Cornwell EW, Mirbod A, Wu CL, Kandarian SC, Jackman RW: C26 cancer-induced muscle wasting is IKKbeta-dependent and NF-kappaB-independent. PLoS One 2014,9(1):e87776. 10.1371/journal.pone.0087776
10. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, et al.: IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004,119(2):285-98. 10.1016/j.cell.2004.09.027
11. Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, et al.: JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 2012,303(3):E410-21. 10.1152/ajpendo.00039.2012
12. Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, Koniaris LG, et al.: STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 2011,6(7):e22538. 10.1371/journal.pone.0022538
13. Zhang G, Jin B, Li YP: C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J 2011,30(20):4323-35. 10.1038/emboj.2011.292
14. Moore-Carrasco R, Garcia-Martinez C, Busquets S, Ametller E, Barreiro E, Lopez-Soriano FJ, et al.: The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia. FEBS Lett 2006,580(2):691-6. 10.1016/j.febslet.2005.12.084
15. Penna F, Costamagna D, Fanzani A, Bonelli G, Baccino FM, Costelli P: Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition. PLoS One 2010,5(10):e13604. 10.1371/journal.pone.0013604
16. Reed SA, Sandesara PB, Senf SM, Judge AR: Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J 2012,26(3):987-1000. 10.1096/fj.11-189977
17. Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, et al.: Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Ther 2007,14(12):945-52. 10.1038/sj.cgt.7701091
18. Skorokhod A, Bachmann J, Giese NA, Martignoni ME, Krakowski-Roosen H: Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia. BMC Cancer 2012, 12:265. 10.1186/1471-2407-12-265
19. Senf SM, Dodd SL, Judge AR: FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am J Physiol Cell Physiol 2010,298(1):C38-45. 10.1152/ajpcell.00315.2009
20. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr, et al.: Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2002,28(2):158-67. 10.1016/S1046-2023(02)00220-7
21. Pacak CA, Walter GA, Gaidosh G, Bryant N, Lewis MA, Germain S, et al.: Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D. Mol Ther 2007,15(10):1775-81. 10.1038/sj.mt.6300246
22. Falk DJ, Mah CS, Soustek MS, Lee KZ, Elmallah MK, Cloutier DA, et al.: Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol Ther 2013,21(9):1661-7. 10.1038/mt.2013.96
23. Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, et al.: Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 2004,10(4):671-8. 10.1016/j.ymthe.2004.07.016
24. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2002,2(1):81-91. 10.1016/S1535-6108(02)00086-7
25. Ito Y, Daitoku H, Fukamizu A: Foxo1 increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 2009,378(2):290-5. 10.1016/j.bbrc.2008.11.043
26. Roberts BM, Ahn B, Smuder AJ, Al-Rajhi M, Gill LC, Beharry AW, et al.: Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J 2013,27(7):2600-10. 10.1096/fj.12-222844
27. Roberts BM, Frye GS, Ahn B, Ferreira LF, Judge AR: Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Biochem Biophys Res Commun 2013,435(3):488-92. 10.1016/j.bbrc.2013.05.018
28. Beharry AW, Sandesara PB, Roberts BM, Ferreira LF, Senf SM, Judge AR: HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy. J Cell Sci 2014,127(Pt 7):1441-53.
29. Senf SM, Sandesara PB, Reed SA, Judge AR: p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. Am J Physiol Cell Physiol 2011,300(6):C1490-501. 10.1152/ajpcell.00255.2010
30. Kuehn H, Liberzon A, Reich M, Mesirov JP: Using GenePattern for gene expression analysis. Curr Protoc Bioinformatics 2008, Chapter 7:Unit 7 12.
31. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003,19(2):185-93. 10.1093/bioinformatics/19.2.185
32. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, et al.: Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005,33(20):e175. 10.1093/nar/gni179
33. NCBI Gene Expression Omnibus. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=cbafomemplujfgp&acc=GSE56555
34. da Huang W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44-57.
35. Broad Institute Molecular Signatures Database. http://www.broadinstitute.org/gsea/msigdb/index.jsp
36. da Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009,37(1):1-13. 10.1093/nar/gkn923
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005,102(43):15545-50. 10.1073/pnas.0506580102
38. Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM, Furlow JD, et al.: The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Am J Physiol Endocrinol Metab 2008,295(4):E785-97. 10.1152/ajpendo.00646.2007
39. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al.: FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007,6(6):458-71. 10.1016/j.cmet.2007.11.001
40. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, et al.: FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007,6(6):472-83. 10.1016/j.cmet.2007.11.004
41. Dellett M, Hu W, Papadaki V, Ohnuma S: Small leucine rich proteoglycan family regulates multiple signalling pathways in neural development and maintenance. Dev Growth Differ 2012,54(3):327-40. 10.1111/j.1440-169X.2012.01339.x
42. Stiber JA, Zhang ZS, Burch J, Eu JP, Zhang S, Truskey GA, et al.: Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity. Mol Cell Biol 2008,28(8):2637-47. 10.1128/MCB.01601-07
43. Frey N, Olson EN: Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J Biol Chem 2002,277(16):13998-4004. 10.1074/jbc.M200712200
44. Zhou Q, Chu PH, Huang C, Cheng CF, Martone ME, Knoll G, et al.: Ablation of Cypher, a PDZ-LIM domain Z-line protein, causes a severe form of congenital myopathy. J Cell Biol 2001,155(4):605-12. 10.1083/jcb.200107092
45. Shum AM, Mahendradatta T, Taylor RJ, Painter AB, Moore MM, Tsoli M, et al.: Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging 2012,4(2):133-43.
46. Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, et al.: BMP signaling controls muscle mass. Nat Genet 2013,45(11):1309-18. 10.1038/ng.2772
47. Choi MC, Cohen TJ, Barrientos T, Wang B, Li M, Simmons BJ, et al.: A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol Cell 2012,47(1):122-32.
48. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, et al.: Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 2007,21(1):140-55.
49. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al.: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004,18(1):39-51. 10.1096/fj.03-0610com
50. Stevenson EJ, Giresi PG, Koncarevic A, Kandarian SC: Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 2003,551(Pt 1):33-48.
51. Rothenberg C, Monteiro MJ: Ubiquilin at a crossroads in protein degradation pathways. Autophagy 2010,6(7):979-80. 10.4161/auto.6.7.13118
52. Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Suzuki T, Ichiyama A, et al.: IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2. Biochem Biophys Res Commun 1999,256(1):127-32. 10.1006/bbrc.1999.0289
53. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al.: Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004,117(3):399-412. 10.1016/S0092-8674(04)00400-3
54. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, et al.: Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005,115(9):2382-92. 10.1172/JCI23126
55. Hernandez-Ochoa EO, Schachter TN, Schneider MF: Elevated nuclear Foxo1 suppresses excitability of skeletal muscle fibers. Am J Physiol Cell Physiol 2013,305(6):C643-53. 10.1152/ajpcell.00003.2013
56. Birkenkamp KU, Essafi A, van der Vos KE, da Costa M, Hui RC, Holstege F, et al.: FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1. J Biol Chem 2007,282(4):2211-20. 10.1074/jbc.M606669200
57. Jen Y, Weintraub H, Benezra R: Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev 1992,6(8):1466-79. 10.1101/gad.6.8.1466
58. Fluck M, Mund SI, Schittny JC, Klossner S, Durieux AC, Giraud MN: Mechano-regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci U S A 2008,105(36):13662-7. 10.1073/pnas.0805365105
59. Zou Y, Zhang RZ, Sabatelli P, Chu ML, Bonnemann CG: Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem. J Neuropathol Exp Neurol 2008,67(2):144-54. 10.1097/nen.0b013e3181634ef7
60. Roberts EW, Deonarine A, Jones JO, Denton AE, Feig C, Lyons SK, et al.: Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med 2013,210(6):1137-51. 10.1084/jem.20122344
61. Urciuolo A, Quarta M, Morbidoni V, Gattazzo F, Molon S, Grumati P, et al.: Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat Commun 2013, 4:1964.